Clinical trials sponsored by Gan & Lee Pharmaceuticals.
8
Recruiting trials
9
Conditions studied
Phase breakdown
Phase 1 4Phase 3 4
Conditions studied
| Condition | Trials |
|---|---|
| Obesity | 6 |
| Type 2 diabetes | 3 |
| Obesity/Overweight | 2 |
| Diabetes | 1 |
| Obesity or Overweight | 1 |
| Obesity&T2D | 1 |
| Obesity/Overweight in Adult | 1 |
| Overweight or Obesity | 1 |
| Type 2 Diabetes (T2DM) | 1 |
Recruiting trials led by Gan & Lee Pharmaceuticals.
- A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
- Bioequivalence Study of GZR18 Injection Before and After CMC Change
- Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
- Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
- Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
- Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
- Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
- Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
Common questions
How many trials is Gan & Lee Pharmaceuticals. recruiting for?
Gan & Lee Pharmaceuticals. is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.